In line with the details reviewed by Marlet (187) and Erbil (188), we also found that there were very limited studies reporting negative results for neuroprotective effects of GLP-1 and GLP-1 RAs and publication bias favoring positive outcomes
No single peptide dominates the literature research is split across four categories by mechanism: incretin-pathway compounds like GLP-3 RT, fragment-based lipolytic peptides like AOD-9604, growth-hormone-releasing analogs like Tesamorelin, and secretagogue pairings like CJC-1295/Ipamorelin
The liquid should be completely transparent, with no visible powder, specks, or cloudiness
2K) staining, respectively
Successful treatment of binge eating disorder with the GLP-1 agonist semaglutide: A retrospective cohort study
Table 2 Data mining methods and specific formulas